GPhA’s New VP-Regulatory Sciences Has Expertise In Generic Injectable Business

During nine years at Ben Venue, Gaugh was responsible for strategic planning, financial management, business development, marketing and sales for the company’s $500 million branded generic injectable business, which is now struggling with manufacturing challenges.